TORONTO, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSX-V: TELO) (OTC: TDSGF) (the “Company” or “TELO”) is pleased to announce that it has engaged Leede Jones Gable Inc. and Mackie Research Corporation (the “Brokers”) to solicit and facilitate, on a commercially reasonable efforts basis, the exercise of warrants issued pursuant to the Company’s financing announced November 25th, 2019 (the “Warrants”). TELO has 8,677,500 Warrants outstanding with an exercise price $0.20 per share which expire on November 25th, 2020. In connection with the engagement, the Brokers will be paid a fee of 4% of the gross proceeds received by TELO from the exercise of the Warrants.
See original here:
Telo Genomics Announces Warrant Exercise Agreement
Recommendation and review posted by Fredricko
